https://www.selleckchem.com/pr....oducts/Cediranib.htm
Sleep Apnea Syndrome (SAS) is a multimorbid chronic disease with individual and societal deleterious consequences. Polysomnography (PSG) is the multi-parametric reference diagnostic tool that allows a manual quantification of the apnea-hypopnea index (AHI) to assess SAS severity. The burden of SAS is affecting nearly one billion people worldwide explaining that SAS remains largely under-diagnosed and undertreated. The development of an easy to use and automatic solution for early detection and screening of SAS is highly desirable. We
Like
Comment
Share
